|
|
Volumn 44, Issue 6, 2006, Pages 1186-1195
|
|
From viral pathobiology to the treatment of hepatitis B virus infection EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 AMINO 9 (1 PHOSPHONOMETHOXYCYCLOPROPYLMETHYL)PURINE BIS(PIVALOYLOXYMETHYL) ESTER;
ADEFOVIR;
ADEFOVIR DIPIVOXIL;
ALANINE AMINOTRANSFERASE;
CLEVUDINE;
ELVUCITABINE;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ENTECAVIR;
HEPATITIS B ANTIBODY;
HEPATITIS B ANTIGEN;
HEPATITIS VACCINE;
IMMUNOGLOBULIN M;
INTERLEUKIN 12;
INTERLEUKIN 2;
LAMIVUDINE;
MIV 210;
NUCLEOSIDE DERIVATIVE;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
TELBIVUDINE;
TENOFOVIR;
TENOFOVIR DISOPROXIL;
THYMOSIN ALPHA1;
UNCLASSIFIED DRUG;
VALTORCITABINE;
ABSENCE OF SIDE EFFECTS;
ACUTE HEPATITIS;
ALCOHOL CONSUMPTION;
ARTICLE;
CLINICAL TRIAL;
CYTOPATHOGENIC EFFECT;
DELTA AGENT HEPATITIS;
DIABETES MELLITUS;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
ENZYME INHIBITION;
GENE EXPRESSION;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGICAL TOLERANCE;
INNATE IMMUNITY;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
MONOTHERAPY;
OBESITY;
PERSISTENT VIRUS INFECTION;
PRIORITY JOURNAL;
REMISSION;
SEROCONVERSION;
SIDE EFFECT;
T LYMPHOCYTE;
TREATMENT OUTCOME;
VIREMIA;
VIRION;
VIRUS GENOME;
VIRUS MUTATION;
VIRUS PATHOGENESIS;
VIRUS REPLICATION;
VIRUS RESISTANCE;
HEPATITIS B;
HEPATITIS B ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
VIREMIA;
|
|
EID: 33646146156
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jhep.2006.03.004 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
